Point72 Hong Kong LTD Fulcrum Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $18,879 - $107,880	4,495 New	4,495 $22,000
Q1 2022 May 16, 2022	SELL	$9.96 - $23.65 $9,780 - $23,224	-982 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $13,748 - $27,928	982 New	982 $17,000
Q2 2021 Aug 16, 2021	SELL	$8.09 - $12.0 $728 - $1,080	-90 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.94 - $15.32 $984 - $1,378	90 New	90 $1,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.